Page last updated: 2024-09-03

rc 3095 and neuromedin b

rc 3095 has been researched along with neuromedin b in 2 studies

Compound Research Comparison

Studies
(rc 3095)
Trials
(rc 3095)
Recent Studies (post-2010)
(rc 3095)
Studies
(neuromedin b)
Trials
(neuromedin b)
Recent Studies (post-2010) (neuromedin b)
108226252256

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arencibia, JM; Cai, RZ; Groot, K; Halmos, G; Kahán, Z; Schally, AV; Sun, B1
Ko, MC; Su, PY1

Other Studies

2 other study(ies) available for rc 3095 and neuromedin b

ArticleYear
Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II.
    Cancer, 2000, Mar-15, Volume: 88, Issue:6

    Topics: Animals; Antineoplastic Agents; Bombesin; Breast Neoplasms; Carcinoma; Dose-Response Relationship, Drug; ErbB Receptors; Female; Gastrin-Releasing Peptide; Gene Expression Regulation, Neoplastic; Humans; Injections, Subcutaneous; Mice; Mice, Nude; Neoplasm Transplantation; Neurokinin B; Peptide Fragments; Polymerase Chain Reaction; Receptors, Bombesin; Remission Induction; RNA, Messenger; Transplantation, Heterologous; Tumor Cells, Cultured

2000
The role of central gastrin-releasing peptide and neuromedin B receptors in the modulation of scratching behavior in rats.
    The Journal of pharmacology and experimental therapeutics, 2011, Volume: 337, Issue:3

    Topics: Animals; Bombesin; Dose-Response Relationship, Drug; Gastrin-Releasing Peptide; Indoles; Infusions, Intraventricular; Male; Neurokinin B; Neurotransmitter Agents; Peptide Fragments; Pruritus; Pyridines; Rats; Rats, Wistar; Receptors, Bombesin

2011